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Introduction
To assess Benin’s pharmacovigilance system, identify the
gaps and define strategy which could lead to its functional
establishment, structure questionnaires was applied to
investigate physicians, pharmacists and pharmaceutical
industry representatives’ knowledge, attitude and practice
regarding Adverse Drug Reactions (ADRs) reporting.
Methods
Indicator-based Pharmacovigilance Assessment Tool
(IPAT) was also used to assess the current landscape
with different stakeholders.
Results
30.77% physicians and 31.11% pharmacists acknowledged
that they faced at least one time ADRs suspected to be
associated with antimalarial drug (P-value < 0.01). How-
ever none of the physicians or the pharmacists has ever
reported ADRs to the national pharmacovigilance service.
The main reasons for not reporting were ‘‘yellow card not
available’’ and “not aware about the existence of pharma-
covigilance center”. 6.97 % of representatives of the phar-
maceutical companies monitored the safety of their
products and none of them have ever reported ADRs to
the health authority (DPM). In return, none of the labora-
tories have ever received a report related to quality or
ADRs related to their drugs on the market from DPM.
IPAT led to low overall scores indicating that there is no
functional pharmacovigilance system in place. The major
shortcoming is the lack of expertise in pharmacovigilance
despite the availability of qualified human resource in the
country.
Conclusion
There is a need to identify and implement adequate
human resources use in order to build capacity and sus-
tain the drug safety system for essential medicines. Faculty
of Medicine and researchers should be involved for the
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